home   genetic news   bioinformatics   biotechnology   literature   journals   ethics   positions   events   sitemap
 
  HUM-MOLGEN -> Events -> Meetings and Conferences  
 

IBC's Antibody Therapeutics

 
  August 31, 2004  
     
 
IBC Life Sciences, Sheraton San Diego Hotel & Marina, San Diego, CA
November 30-December 3, 2004


IBC’s 2nd International Antibody Therapeutics conference covers key aspects of the development of antibodies as therapeutic products, including: capital market, clinical trials and regulatory environment; business development, technology transfer and partnering strategies; technology highlights; clinical study status of pre-clinical and clinical development of recombinant antibodies; production; and a panel discussion covering complex intellectual property issues of the antibody sector. IBC’s 2nd Antibody Therapeutics is co-located with IBC’s 15th Antibody Engineering conference, which gives attendees access to selected sessions at the Antibody Engineering conference and full access to the shared exhibit and poster hall and networking functions. To register for Antibody Therapeutics, visit www.IBCLifeSciences.com/3062 or call IBC at +1-508-616-5550 x1004.
 
 
Organized by: IBC Life Sciences
Invited Speakers: Keynote Addresses:
Ronald Levy, M.D., Stanford School of Medicine
Jenny P. Mather, Ph.D., Raven Biotechnologies, Inc.
 
Deadline for Abstracts: -
 
Registration: Phone: 508-616-5550 Fax: 508-616-5522 Email: reg@ibcusa.com Online: www.IBCLifeSciences.com/3062
E-mail: reg@ibcusa.com
 
   
 
home   genetic news   bioinformatics   biotechnology   literature   journals   ethics   positions   events   sitemap
 
 
 

Generated by meetings and positions 5.0 by Kai Garlipp
WWW: Kai Garlipp, Frank S. Zollmann.
7.0 © 1995- HUM-MOLGEN. All rights reserved. Liability, Copyright and Imprint.